Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Navitas Semiconductor Corporation Common Stock (NVTS) Price & Performance

Cytokinetics IncTrade
Navitas Semiconductor Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Navitas Semiconductor Corporation Common Stock — how do they compare? Cytokinetics Inc trades at $62.02 (market cap $8.50B), while Navitas Semiconductor Corporation Common Stock trades at $11.18 (market cap $2.97B). The key difference: Cytokinetics Inc is far larger — about 2.9× Navitas Semiconductor Corporation Common Stock's market cap, and Navitas Semiconductor Corporation Common Stock is more actively traded (18,229,864 versus 2,395,556). Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Navitas Semiconductor Corporation Common Stock for 0 Days on average.

CYTKNVTS
Market Cap
$8.50B$2.97B
Volume
2,395,55618,229,864
Sector
HealthTechnology
52-Week High
$87.26$31.79
52-Week Low
$54.76$7.14
Typical Hold Time
19 Days0 Days
Enterprise Value
$8.60B$2.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

CYTK trades at $61.12, down 0.37% on the day, with a bearish technical signal from moving averages but bullish momentum from oscillators. The company reported a net loss of -$784.96M on $88.04M revenue in 2025, with a negative net income margin of -1,321.12%. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy, including Phase 3 results and real-world study launches.

Despite heavy losses, strong analyst consensus (97.14% buy ratings) and a $112.50 price target reflect optimism for its heart failure pipeline. Key risks include sustained cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization to justify its high P/S ratio of 112.42.

Navitas Semiconductor Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CYTK
100% Buy0% Sell
Avg holding period · 19 Days
NVTS
100% Buy0% Sell
Avg holding period · 0 Days

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK →

About Navitas Semiconductor Corporation Common Stock

Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.

Read more on NVTS →